Glowside was the lead financial advisor of Recipharm
Glowside was the lead financial advisor of Recipharm on the carve out and sale of Medicamenta and Davi for approximately Eur 31 M.
Glowside was the lead financial advisor of Recipharm on the carve out and sale of Medicamenta and Davi for approximately Eur 31 M.
Boardroom Advisory
Restructuring & Transformation
Business Planning & Valuation
M&A (Mergers & Acquisitions)
Debt Advisory
